fondaparinux and Myelodysplastic-Syndromes

fondaparinux has been researched along with Myelodysplastic-Syndromes* in 1 studies

Other Studies

1 other study(ies) available for fondaparinux and Myelodysplastic-Syndromes

ArticleYear
Paroxysmal nocturnal hemoglobinuria following alemtuzumab immunosuppressive therapy for myelodysplastic syndrome and complicated by recurrent life-threatening thrombosis despite anticoagulation: successful intervention with eculizumab and fondaparinux.
    Leukemia research, 2010, Volume: 34, Issue:4

    Topics: Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Anticoagulants; Fondaparinux; Hemoglobinuria, Paroxysmal; Humans; Immunosuppressive Agents; Male; Middle Aged; Myelodysplastic Syndromes; Polypharmacy; Polysaccharides; Recurrence; Thrombosis; Treatment Outcome

2010